Healthcare providers face substantial pressure to manage cost and improve care for an expanding patient population. According to Centers for Medicare & Medicaid Services, between 2011 and 2013, health spending is projected to grow faster due to expected improvements in the economy, reaching a rate of 5.5 percent by 2013. In 2014, health spending is projected to grow 8.3 percent. This projected acceleration in the growth rate, up from 5.5 percent in 2013, is primarily the result of the Affordable Care Act’s coverage - related expansions.

The demographic blip represented by baby boomers with the attendant medical issues that accompanied aging also complicates the equation.

For these reasons, Sensiotec Inc. has made it a commitment to design and deliver a non-contact remote vital signs monitoring solution - a solution that supports evidenced-based medicine and better financial outcomes by helping healthcare providers manage cost, reduce risk, enhance productivity, improve quality care and increase patient satisfaction.

We have developed The Virtual Medical Assistant™, the world’s first truly remote, noncontact vital signs monitoring solution. The Virtual Medical Assistant™ monitors multiple patients safely and comfortably at a fraction of the cost of conventional systems, supporting evidenced-based medicine and better financial outcomes by helping healthcare providers manage cost, reduce risk, enhance productivity, improve quality of care and increase patient satisfaction. The Virtual Medical Assistant™ technology has received FDA 510(k) Class II premarket clearance and is in market trials.

Operating at a fraction of the cost of conventional telemetry systems, The Virtual Medical Assistant™ monitors heart and respiration rates and movement without pressure pads, sensors or cuffs that touch the patient. Consisting of a lightweight panel at the point of care that can be placed above, below or next to a bed, The Virtual Medical Assistant™ provides a constant feedback loop starting from its bed sensor panel at the point of care and going out to nurses’ stations, tablets, pagers or smart phones.

The Virtual Medical Assistant™ acquires data every two seconds, providing spot data and analyzing trends, to tell whether a patient is experiencing deteriorating heart and respiratory readings, is in danger of falling, or requires pressure ulcer prevention management.

Disruptive Innovation

At the point of care, The Virtual Medical Assistant™ utilizes Ultra-Wideband (“UWB”), a formerly military-classified, high frequency low power radar technology. UWB produces no ionizing radiation, generates high temporal and spatial resolutions, penetrates solid objects and body tissue, produces ultra-low power specific absorption rates, and accommodates established narrowband systems.

We have developed proprietary UWB-based technology that “sees inside the body” by acquiring and processing patient data at the point of care through the transmission of nanosecond pulses, more than 20 million times weaker than a cell phone, that detect micro movements from the heart, lungs and torso, that are digitally separated, filtered and processed to generate critical heart, respiration and movement data. This data streams continuously via our ZigBee® wireless mesh network utilizing a scalable client-server architecture.

Today, it is not enough to create healthcare technology that can save lives.  The product must demonstrate economic value. In other words, can it help contain or reduce costs? This is exactly what Sensiotec is addressing through our value propositions that are unparalleled.

Currently, we are conducting market trials and are participating in clinical studies to demonstrate the value of The Virtual Medical Assistant™ in the following areas:

• Predicting and preventing patient falls,
• Improving pressure ulcer management protocols,
• Improving response times to Code Blue and other critical patient alerts,
• Reducing morbidity and mortality resulting from PCA-pump drug overdoses.

These market trials and clinical studies are also examining the effect of The Virtual Medical Assistant™ in reducing ICU lengths of stay for certain patient categories, increasing labor productivity, and monitoring step down units.

Georgia Tech

Smart Antenna Research Lab

Interactive Media Technology Center

Everyday Computing Lab

Institute for People & Technology

Manufacturing Research Center

Aware Home

Georgia Tech Research Institute

Home Lab

Electro-Optical Systems Laboratory

Global Center for Manufacturing Innovation

Robert Arkin, Chief Executive Officer

• C-level executive with liquidity event track record
• Former health, HIT & internet industry CEO, COO & CLO
• Former partner, Top 200 law firm
• University of Virginia Law JD, UPenn MA, BA cum laude

Neal Templeton, MD, Chief Medical Officer

• Founder and CMO, Optimal IMX; former CMO, Emageon 
• Former President & Chairman, American College of Radiology
• Former BHS Trustee & Finance Committee Chair

Mary Ann Ingram, PhD, Chief Technology Officer

• Professor of Engineering and Telecommunications, Electrical and Computer Engineering, Georgia Tech
• Founder and Director, Smart Antenna Research Laboratory

Robert Rupard, Chief Operating Officer

• Early stage C-level executive
• Startup and operations expertise

Bernard Harris, MD, MMS, MBA, Chairman

• Immediate Past President, American Telemedicine Assoc.
• Former Astronaut
• Associate Professor of Internal Medicine, University of Texas
• Clinical Professor, Baylor College of Medicine
• Managing Partner, Vesalius Ventures

Lt. General Andy Anderson, MD (USAF, retired)

• Former Surgeon General, US Air Force
• Dean, U. of Missouri - Kansas City School of Medicine
• CEO, American Medical Association

Lt. Colonel Shean Phelps, MD, MPH (US Army, retired)

• Director, Health Systems Technology R&D, Georgia Tech Research Institute
• Former Director, Warfighter Protection Division, Aeromedical Research Laboratory

Brian Jones

• Senior Research Engineer, GTRI; Director, Aware Home

Kevin Maher, MD, Principal Investigator

• Children’s Healthcare of Atlanta - Founding Member/Associate irector, Center for Pediatric Nanomedicine; Director, Pediatric Cardiac Nanomedicine; Pediatric Cardiologist, Sibley Heart Center
• Emory School of Medicine. Associate Professor of Pediatrics
• Atlanta Pediatric Device Consortium Assoc. Director

Dr. Richard Carmona, MD, MPH, FACS, 17th U.S. Surgeon General

• Vice Chairman of Canyon Ranch, a health and wellness company; and President of the non-profit Canyon Ranch Institute.
• Distinguished Professor at the Mel and Enid Zuckerman College of Public Health at the University of Arizona.
• Dr. Carmona will provide strategic counsel to the company on clinical, scientific and commercialization strategies.

We have received grants from the following institution:

Atlantic Pediatric Device Consortium

• Development of noncontact apnea bradycardia monitor for neonates, infants & children (hospital and home)

GCI Research and Commercialization Grant

• Design and development of software

Center for Pediatric Innovation - Georgia Tech’s Petit Institute for Bioengineering and Bioscience and Children’s Healthcare of Atlanta

• Non-contact Vital Signs Monitoring for Neonates, Babies and Small Children